Sharp and colleagues reported that the MTHFR A1298C SNP in a case-control study (62 women and 64 controls) reduced breast cancer risk in women with the 1298CC genotype compared to that of the AA genotype in the Scotland population (Sharp et al., 2002). Here, MTHFR is linked to breast carcinoma.